Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Differentiation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03567655
What this trial is testing

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Asan Medical Center 41
Early research (Phase 1)Study completedNCT00470197
What this trial is testing

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 35
Not applicableUnknownNCT04858867
What this trial is testing

Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

Who this might be right for
Differentiated Thyroid Cancer
Leiden University Medical Center 12
Post-approval studies (Phase 4)Study completedNCT01451034
What this trial is testing

Clinical Outcomes of Endoscopic Resection for Treating WHYX Lesion

Who this might be right for
WHYX LesionExtremely Well Differentiated Intestinal-type Adenocarcinoma
Samsung Medical Center 872
Not applicableNot Yet RecruitingNCT06845098
What this trial is testing

Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer

Who this might be right for
Thyroid Gland
Zhejiang Provincial People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT00528398
What this trial is testing

Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 111
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Large-scale testing (Phase 3)Study completedNCT00006363
What this trial is testing

Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Erythroid Leukemia (M6)+30 more
National Cancer Institute (NCI) 720
Not applicableStudy completedNCT00828516
What this trial is testing

Using Traditional Acupuncture in the Management of Cancer Treatment Related Lymphoedema

Who this might be right for
Breast CancerHead and Neck CancerLymphedema
East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Looking for participantsNCT06235216
What this trial is testing

Sacituzumab govitEcan in THYroid Cancers

Who this might be right for
Differentiated Thyroid CancerAnaplastic Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos 42
Not applicableActive Not RecruitingNCT05913687
What this trial is testing

Automated Imaging Differentiation of Parkinsonism

Who this might be right for
Parkinson DiseaseMultiple System Atrophy, Parkinson VariantProgressive Supranuclear Palsy
University of Florida 315
Early research (Phase 1)Study completedNCT01127009
What this trial is testing

Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Case Comprehensive Cancer Center 3
Not applicableUnknownNCT01700699
What this trial is testing

Impact of BRAFV600E Intratumor Heterogeneity in Thyroid Cancer Treated With Tyrosine Kinase Inhibitors

Who this might be right for
Differentiated Thyroid Cancer
University of Salerno 50
Testing effectiveness (Phase 2)Ended earlyNCT00707473
What this trial is testing

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

Who this might be right for
Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaNasal Cavity and Paranasal Sinus Poorly Differentiated CarcinomaSinonasal Undifferentiated Carcinoma+4 more
M.D. Anderson Cancer Center 31
Early research (Phase 1)Study completedNCT02800070
What this trial is testing

Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease

Who this might be right for
Fabry Disease
University Health Network, Toronto 5
Testing effectiveness (Phase 2)WithdrawnNCT04903054
What this trial is testing

Selective CD28 Blockade in Renal Transplant Recipients

Who this might be right for
Kidney TransplantationRenal Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00454077
What this trial is testing

RhTSH-Thyroid Ablation With 1850 MBq of 131I

Who this might be right for
Thyroid Cancer
University of Siena 72
Not applicableLooking for participantsNCT07545837
What this trial is testing

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

Who this might be right for
Thyroid Gland Follicular CarcinomaThyroid Gland Papillary Carcinoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02698410
What this trial is testing

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.

Who this might be right for
Neuroendocrine Tumours
Ipsen 40
Not applicableUnknownNCT03438370
What this trial is testing

Outcomes of Differentiated Models of Antiretroviral Treatment (ART) Provision

Who this might be right for
HIV/AIDS
Equip, Lesotho 5,760
Next Page